Doxycycline covers an unusually broad range of bacteria, including many gram-positive, gram-negative, and atypical organisms. It’s one of the most versatile antibiotics prescribed today, used for everything from acne and sexually transmitted infections to tick-borne illnesses and malaria prevention. Here’s a breakdown of what it treats and why it works so widely.
How Doxycycline Works
Doxycycline is bacteriostatic, meaning it stops bacteria from growing rather than killing them outright. It does this by binding to a specific part of the bacterial ribosome (the machinery bacteria use to build proteins) and blocking the delivery of amino acids during protein assembly. Without the ability to produce essential proteins, bacteria can’t multiply and eventually die off as your immune system clears the stalled infection.
This mechanism targets a structure shared across many bacterial species, which is why doxycycline’s coverage is so broad compared to antibiotics that attack a single type of cell wall or enzyme.
Gram-Positive Bacteria
Doxycycline is active against several important gram-positive organisms. These include the bacteria responsible for anthrax (Bacillus anthracis), the foodborne pathogen Listeria, and Streptococcus pneumoniae, a leading cause of pneumonia, sinus infections, and ear infections. It also has activity against some strains of Staphylococcus aureus, including certain community-acquired MRSA strains, which makes it a useful oral option for skin and soft tissue infections when MRSA is suspected.
Gram-Negative Bacteria
The gram-negative coverage is extensive. According to FDA-approved labeling, doxycycline is active against:
- Respiratory pathogens: Haemophilus influenzae, Klebsiella species
- Gastrointestinal pathogens: Vibrio cholerae (cholera), Shigella species, Campylobacter fetus
- Rare but serious infections: Yersinia pestis (plague), Francisella tularensis (tularemia), Brucella species (brucellosis), Bartonella bacilliformis (bartonellosis)
- Sexually transmitted pathogens: Neisseria gonorrhoeae, Haemophilus ducreyi (chancroid), Klebsiella granulomatis (granuloma inguinale)
- Other: Acinetobacter species, Enterobacter aerogenes, Escherichia coli
For some of these organisms, like E. coli and Shigella, susceptibility testing is recommended before relying on doxycycline, since resistance rates vary by region.
Atypical Bacteria
One of doxycycline’s most clinically valuable roles is covering “atypical” bacteria, organisms that lack a traditional cell wall and don’t respond to antibiotics like penicillin. This group includes Mycoplasma pneumoniae (a common cause of walking pneumonia), Chlamydia trachomatis (the most frequently reported bacterial STI), and Ureaplasma species (linked to urogenital infections and fertility problems).
For Ureaplasma specifically, doxycycline has shown better eradication rates than azithromycin. In one study of couples undergoing fertility treatment, azithromycin failed to clear the infection in 50% of cases compared to roughly 10% failure with doxycycline. This led researchers to switch to doxycycline as their first-line treatment.
Tick-Borne and Rickettsial Diseases
Doxycycline is the single most important antibiotic for tick-borne infections, and for rickettsial diseases it has no proven equal. The CDC has stated that no alternative antibiotic matches doxycycline’s ability to prevent fatal outcomes in Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis. Even chloramphenicol, sometimes mentioned as a backup, carries a significantly higher risk of death when used for these infections.
For Lyme disease, doxycycline is one of several effective treatment options alongside amoxicillin and cefuroxime. But it holds a unique advantage: it’s the only antibiotic recommended for post-tick-bite prophylaxis. If you find an engorged deer tick and want to reduce your risk of developing Lyme disease, a single dose of doxycycline is the standard approach. No other antibiotic has been tested for this preventive use.
Sexually Transmitted Infections
Beyond treating active chlamydia infections, doxycycline has a newer and increasingly important role in STI prevention. In 2024, the CDC issued guidelines recommending doxycycline post-exposure prophylaxis (doxy-PEP) for men who have sex with men and transgender women who’ve had a bacterial STI in the past year.
The approach is straightforward: 200 mg taken within 72 hours after sex. Across three large randomized trials, this reduced syphilis and chlamydia infections by more than 70% and gonorrhea by roughly 50%. One trial found chlamydia risk dropped by as much as 88% in certain groups. The CDC rated this a strong recommendation backed by high-quality evidence.
Malaria Prevention
Doxycycline is one of the primary options for malaria prophylaxis when traveling to endemic areas. The CDC recommends 100 mg daily for adults, starting one to two days before entering the malaria zone, continuing daily throughout the trip, and for 28 consecutive days after leaving. It’s often chosen by travelers heading to regions where the malaria parasite is resistant to other preventive drugs, or by those who want a lower-cost option compared to alternatives.
Skin Conditions: Acne and Rosacea
Doxycycline pulls double duty in dermatology. At standard antimicrobial doses (50 to 100 mg daily), it helps control moderate to severe acne by reducing the bacteria involved in inflammatory breakouts. But it also works at much lower “subantimicrobial” doses (around 20 mg) through a completely different pathway. At these doses, it doesn’t fight bacteria at all. Instead, it reduces inflammation directly by blocking enzymes that break down collagen and by dialing down inflammatory signaling molecules in the skin.
This anti-inflammatory property makes low-dose doxycycline useful for rosacea, where the redness and bumps are driven by inflammation rather than infection. The subantimicrobial dosing carries a lower risk of antibiotic resistance since it doesn’t exert selective pressure on bacteria.
Who Should Avoid Doxycycline
Doxycycline belongs to the tetracycline class, which has historically been restricted during pregnancy and in children under 8 due to concerns about permanent tooth discoloration and potential harm to fetal development. The FDA previously classified it as a Category D drug in pregnancy. However, recent evidence has prompted a rethinking of these restrictions. Reviews of the available data suggest doxycycline is likely safe in early pregnancy and for short courses in young children at doses not exceeding 200 mg per day for up to 14 days. The American Academy of Pediatrics revised its guidelines to support doxycycline use in young children for serious conditions like Rocky Mountain spotted fever, where the risk of the disease far outweighs the theoretical risk of tooth staining.
That said, prolonged use during the second and third trimesters and in children during tooth development still warrants caution. For most other adults, doxycycline is well tolerated, with the most common side effects being nausea (especially on an empty stomach) and increased sun sensitivity.